title: Treatment outcomes for Mycobacterium avium complex: a systematic review and meta-analysis.
abstract: To evaluate the existing evidence regarding treatment regimens for Mycobacterium avium complex (MAC), a systematic review of the available therapeutic studies was conducted to assess treatment outcomes. A random-effects meta-analysis was used to assess treatment outcomes. Subgroup analyses were also conducted by separating studies based on each characteristic independently. Twenty-eight trials met the inclusion criteria. Our meta-analysis showed that the estimated pooled treatment success rate for patients with MAC disease was 39 % [95 % confidence interval (CI) 38-41 %]. The rates of failure, relapse, death, and default were 27 % (95 % CI 25-29 %), 6 % (95 % CI 5-7 %), 17 % (95 % CI 15-18 %), and 12 % (95 % CI 11-13 %), respectively. The proportion of patients treated successfully did not differ significantly on the basis of the study characteristics. However, studies with treatment regimens containing macrolides had significantly higher pooled success proportions (42 %, 95 % CI 40-44 %) than that of other studies (28 %, 95 % CI 24-32 %). Substantial heterogeneity in the study characteristics prevented more conclusive determination of what factors had the greatest effect on the proportion of patients that achieve treatment success and limited the validity of this analysis. This review underscored the importance of strong patient support and treatment follow-up systems to develop successful MAC treatment programs.
authors: Department of Clinical Pharmacy, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China, xuhongbin@tongji.edu.cn.
authors: H-B
authors: HB
authors: Xu
authors: R-H
authors: RH
authors: Jiang
authors: L
authors: L
authors: Li
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D015658:HIV Infections / Q000382:microbiology; D006801:Humans; D015269:Mycobacterium avium Complex; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy* / Q000821:virology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents
references: Thorax. 2001 Mar;56(3):167-72
references: 11182006
references: Clin Infect Dis. 2000 Feb;30(2):288-92
references: 10671330
references: Drug Saf. 1999 Aug;21(2):137-52
references: 10456381
references: AIDS. 1997 Mar;11(3):311-7
references: 9147422
references: Lancet. 1999 Nov 27;354(9193):1896-900
references: 10584742
references: Emerg Infect Dis. 2011 Mar;17(3):343-9
references: 21392422
references: Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1766-72
references: 8665032
references: Clin Infect Dis. 2000 Nov;31(5):1245-52
references: 11073759
references: Clin Infect Dis. 1999 May;28(5):1080-5
references: 10452638
references: Clin Infect Dis. 1998 Nov;27(5):1278-85
references: 9827282
references: Eur J Clin Microbiol Infect Dis. 1999 Jan;18(1):16-22
references: 10192709
references: N Engl J Med. 1996 Aug 8;335(6):377-83
references: 8676931
references: J Infect Dis. 1997 Nov;176(5):1225-32
references: 9359722
references: Clin Infect Dis. 1999 Jul;29(1):125-33
references: 10433575
references: Clin Infect Dis. 1996 Apr;22(4):705-8
references: 8729209
references: BMJ. 2003 Sep 6;327(7414):557-60
references: 12958120
references: Eur Respir J. 2004 May;23(5):741-6
references: 15176690
references: J Antimicrob Chemother. 1999 Jul;44(1):129-31
references: 10459822
references: Am J Respir Crit Care Med. 1997 Aug;156(2 Pt 2):S1-25
references: 9279284
references: Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416
references: 17277290
references: Ann Intern Med. 1994 Dec 15;121(12):905-11
references: 7978715
references: Int J Tuberc Lung Dis. 2004 Oct;8(10):1186-93
references: 15527150
references: J Infect Dis. 1994 Jul;170(1):157-64
references: 8014492
references: Ann Intern Med. 1992 Mar 15;116(6):466-72
references: 1739237
references: Chest. 1995 Apr;107(4):1035-40
references: 7705112
references: Am Rev Respir Dis. 1986 Sep;134(3):438-41
references: 3530069
references: Respir Med. 2007 Jan;101(1):130-8
references: 16750618
references: Int J Tuberc Lung Dis. 1998 Jun;2(6):462-70
references: 9626603
references: Thorax. 2008 Jul;63(7):627-34
references: 18250184
references: J Infect Dis. 1993 Jul;168(1):112-9
references: 8515098
references: Am J Respir Crit Care Med. 2006 Jun 1;173(11):1283-9
references: 16514112
references: Antimicrob Agents Chemother. 1996 Jul;40(7):1722-5
references: 8807071
references: Am J Respir Crit Care Med. 1999 Sep;160(3):866-72
references: 10471610
references: Infection. 1997 Jan-Feb;25(1):16-21
references: 9039532
references: Chin Med J (Engl). 2010 Jan 20;123(2):184-7
references: 20137367
references: Antimicrob Agents Chemother. 1999 Dec;43(12):2869-72
references: 10582873
references: Clin Infect Dis. 2003 Nov 1;37(9):1234-43
references: 14557969